|
Dr. Rosenberg has an extensive background studying HIV. He is best known for his research on early HIV infection, also known as primary HIV infection. His important findings of immune control of HIV infection during structured treatment interruptions in primary infection were previously published and highly cited in journals, including Science and Nature. Dr. Rosenberg is board-certified in Internal Medicine and Infectious Diseases. His research and clinical practice is focused on the immunopathogenesis of HIV infection with additional work related to infectious disease and transplant medicine. Dr. Rosenberg is an Assistant Professor of Medicine at Harvard Medical School, where he has been appointed in various academic capacities since 1995, and is a Staff Physician at the Massachusetts General Hospital in Boston, where he has also been appointed since 1995. He serves in the capacities of Associate Director of the Clinical Microbiology Laboratory, and Director of the Education Unit of the Clinical Research Program at Massachusetts General Hospital.
Dr. Rosenberg is a member of several professional societies and associations, editorial board member of the Journal of Immune-Based Therapies and Vaccines, and Associate Editor of AIDS Clinical Care. Dr. Rosenberg is Chair of the Treatment Working Group of the National Institutes of Health Acute Infection Early Disease Research Program, and a member of the Massachusetts General Hospital Clinical Research Council.
Dr. Rosenberg has been co-chair, co-principal investigator, and principal investigator of clinical trials focused on HIV treatment, and has been the beneficiary of several NIH awards. He is a regular presenter in the field of HIV infection and has published over 50 articles in the literature. Dr. Rosenberg obtained his MD from the Mount Sinai School of Medicine in New York and completed his internship, assistant residency and chief residency in Internal Medicine at the University of North Carolina. | 